Evidence map›Paper›PMID 42840594›Full record

ArticleHealth science reports2026

National Trends in Utilization and Expenditures for Plastic Surgery From 2002 to 2022: A Cross-Sectional Study.

Jason Zhang, Anitesh Bajaj, Shivani A Shah, Kristian Nenchev, Timothy Burke, Matthew D Ramsey, Hannah Soltani, Michael A Howard, Chad M Teven

Abstract read
In one paragraph

Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jason ZhangDivision of Plastic Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA.ORCID https://orcid.org/0000-0003-4915-453X
Anitesh BajajDivision of Plastic Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA.ORCID https://orcid.org/0000-0001-5392-8433
Shivani A ShahDivision of Plastic Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA.
Kristian NenchevDivision of Plastic Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA.
Timothy BurkeDivision of Plastic Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA.ORCID https://orcid.org/0009-0006-1814-0847
Matthew D RamseyDivision of Plastic Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA.ORCID https://orcid.org/0000-0002-7632-4699
Hannah SoltaniDivision of Plastic Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA.ORCID https://orcid.org/0000-0001-9562-4630
Michael A HowardDivision of Plastic Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA.
Chad M TevenDivision of Plastic Surgery Northwestern University Feinberg School of Medicine Chicago Illinois USA.ORCID https://orcid.org/0000-0002-2835-9942

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: Shifting patterns in the financing of plastic surgery are not fully understood. We analyze payer trends for office and outpatient plastic surgery visits from 2002 to 2022. Methods: We investigated office-based and hospital outpatient department plastic surgery visits in the Medical Expenditure Panel Survey, a national dataset of healthcare usage and expenditures. During the study period (2002-2022), we calculated the yearly median amount of money charged and paid per visit, the distribution of payer type expenditures, and the mean payment-to-charge ratio per visit. Dollar amounts were inflation-adjusted to 2022 estimates. Results: From 2002 to 2022, there were 5824 office-based plastic surgery visits and 850 outpatient department plastic surgery visits, representing 71,597,980 and 10,589,575 total visits, respectively. For office-based visits, the number of visits declined across the study period from 3,982,280 to 1,418,032 (-64.4%), the median (IQR) payment per visit increased from $119.06 ($188.49) to $263.48 ($721.35) (+121.3%), and the median (IQR) payment-to-charge ratio decreased from 0.71 (0.43) to 0.47 (0.45) (-33.8%). Payments were primarily private insurance (37.6%) and out-of-pocket (36.0%). For outpatient department visits, the median (IQR) payment-to-charge ratio also decreased significantly from 0.56 (0.44) to 0.35 (0.45) (-37.1%); median (IQR) payment per visit was $1587.93 ($1287.80) without significant changes over time. Most expenditures were from private insurance (58.5%), then self-pay (17.8%), and Medicare (11.7%). Conclusion: National trends in plastic surgery expenditures show decreasing payment-to-charge ratios for both office and outpatient department settings. However, the payer mix driving these trends differs by practice setting. Limitations of the study include survey-based data, a small sample size, and the exploratory nature of the study with limited statistical analysis. Further research is warranted to uncover factors that may account for these findings and their implications.

Identifiers

PMID42840594
PMCPMC13639539

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.